21 Aug Date 21/08/2022 Categories Vaderis News Vaderis Therapeutics AG announces Clinical Proof-of-Concept Trial in HHT Vaderis is a biotechnology company focusing on treatment of rare and Orphan Diseases caused by Vascular Malformations